What Are The Purported Benefits of Tesamorelin?
Tesamorelin is a well-studied analogue of human Growth Hormone-Releasing Hormone (GHRH) with clinically validated efficacy. It is primarily known for its ability to selectively reduce visceral adipose tissue (VAT), the deep abdominal fat surrounding internal organs, with reductions of 15–20% observed over several months, while sparing subcutaneous fat.
Secondary benefits include improved metabolic health, including lower triglycerides, improved lipid profiles, and reduced liver fat. Tesamorelin, a GH peptide, also promotes natural, pulsatile growth hormone (GH) secretion, supporting overall health. Additionally, preliminary/preclinical research suggests potential cognitive benefits, including improved executive function and verbal memory.
Researchers can buy Tesamorelin for investigation into its effects, including in the convenient Tesamorelin 10 mg vial format for research use.
What Is the Chemical Makeup of Tesamorelin?
Tesamorelin is a synthetic peptide consisting of 44 amino acids, engineered to enhance stability and potency in the bloodstream. As an analogue of human GHRH, Tesamorelin includes a trans-3-hexenoic acid modification attached to the N-terminal tyrosine residue. Despite a short serum half-life of 26-38 minutes, Tesamorelin’s effects on pituitary GH secretion persist, enabling once-daily dosing.
- Chemical Formula: C₂₂₁H₃₆₆N₇₂O₆₇S
- Molecular Weight: 5136 g/mol
- CAS Registry Number: 218949-48-5
- PubChem Compound ID: 44147413
- Synonyms: Tesamorelin, Egrifta
- Purity: ≥99% HPLC
- Appearance: Lyophilized white powder
- Amino Acid Count: 44 (GHRH 1-44 analog)
- Sequence: Trans-3-hexenoyl-YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL-NH2
What Does Scientific Research Say About Tesamorelin?
Tesamorelin has undergone extensive scientific evaluation, including multiple Phase 3 clinical trials. FDA-approved as Egrifta, it is indicated for reducing VAT in HIV-associated lipodystrophy. Research shows that 69% of Tesamorelin-treated patients achieved clinically significant VAT reductions (≥8%) compared to 33% with placebo.
Further studies demonstrate that Tesamorelin preserves glucose metabolism, making it a safer alternative to high-dose HGH therapy. Common side effects reported in clinical trials include mild injection site reactions, muscle aches, and temporary fluid retention.
Documented Adverse Effects
- Common Effects: Injection site reactions (redness, swelling, pain), joint and muscle pain, headache, fluid retention, numbness/tingling (carpal tunnel), nausea, vomiting, sleep disturbances.
- Serious Effects: Allergic reactions (rash, hives), cardiac effects (palpitations, chest pain), vision changes, high blood sugar, prolonged carpal tunnel symptoms.
- Clinical Context: Most adverse effects are mild and transient. Injection site reactions and musculoskeletal pain are most common. Carpal tunnel symptoms and peripheral edema require monitoring and potential dose adjustments.
What Are the Storage Conditions for Tesamorelin?
Proper storage is crucial for maintaining Tesamorelin’s stability and effectiveness.
- Lyophilized Powder (before mixing): Store at controlled room temperature (20–25°C/68–77°F, excursions permitted to 15–30°C/59–86°F), protected from light. Refrigeration optional; do not freeze.
- Reconstituted Solution (after mixing): Store at 2–8°C (36–46°F). For research-grade solutions, use within 2–3 weeks. For FDA-approved products, the recommended use period is within 24 hours. Avoid storing the solution at room temperature, as degradation can occur rapidly.
Are you looking to buy Tesamorelin online?
If you’re looking to order Tesamorelin online at wholesale prices, contact Medical Spa RX for guidance on how to do so.
This product is supplied strictly for laboratory research use only and is not approved for human or veterinary administration. It is not intended for diagnostic, therapeutic, or clinical applications. Any reference to biological activity or potential effects is based solely on preclinical or in-vitro findings and should not be interpreted as validated clinical outcomes. Researchers are responsible for ensuring proper handling, storage, and disposal in accordance with institutional, federal, and international guidelines. By purchasing or using this material, the buyer confirms that they are a qualified researcher and that the product will be used exclusively in controlled research settings compliant with all applicable regulations.
Sources
https://pubmed.ncbi.nlm.nih.gov/20554713
https://pubmed.ncbi.nlm.nih.gov/22869065
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022505Orig1s000ChemR.pdf